{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:10:00Z","timestamp":1792696200765,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T00:00:00Z","timestamp":1765584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"vor","delay-in-days":6,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-32012-y","type":"journal-article","created":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T13:37:15Z","timestamp":1765633035000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Design, synthesis, and multi-target evaluation of 4-phenyl quinoline-8-sulfonate thiosemicarbazones as potential anti-Alzheimer agents"],"prefix":"10.1038","volume":"15","author":[{"given":"Rahma","family":"Saeed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hafiza Zara","family":"Tariq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiysha","family":"Althobaiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nastaran","family":"Sadeghian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parham","family":"Taslimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariya","family":"Al-Rashida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talha","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamdy Khamees","family":"Thabet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hina","family":"Aftab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halil","family":"\u015eenol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mubashir","family":"Ameen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahid","family":"Shafiq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,13]]},"reference":[{"key":"32012_CR1","doi-asserted-by":"publisher","first-page":"132979","DOI":"10.1016\/j.molstruc.2022.132979","volume":"1262","author":"SK Shrivastava","year":"2022","unstructured":"Shrivastava, S. K. et al. Drug reposition-based design, synthesis, and biological evaluation of dual inhibitors of acetylcholinesterase and \u03b2-Secretase for treatment of alzheimer\u2019s disease. J. Mol. Struct. 1262, 132979 (2022).","journal-title":"J. Mol. Struct."},{"key":"32012_CR2","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3390\/molecules28010021","volume":"28","author":"F Rahim","year":"2022","unstructured":"Rahim, F. et al. Synthesis of new triazole-based thiosemicarbazone derivatives as anti-Alzheimer\u2019s disease candidates: Evidence-based in vitro study. Molecules 28, 21 (2022).","journal-title":"Molecules"},{"key":"32012_CR3","first-page":"47","volume":"14","author":"P. N. Tripathi","year":"2024","unstructured":"Tripathi, P. N. et al. Review of pharmacotherapeutic targets in Alzheimer\u2019s disease and its management using traditional medicinal plants. Degener Neurol. Neuromuscul. Disease. 14, 47\u201374 (2024).","journal-title":"Degener Neurol. Neuromuscul. Disease"},{"key":"32012_CR4","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1016\/S0140-6736(17)32399-1","volume":"390","author":"RM Anderson","year":"2017","unstructured":"Anderson, R. M., Hadjichrysanthou, C., Evans, S. & Wong, M. M. Why do so many clinical trials of therapies for alzheimer\u2019s disease fail? Lancet 390, 2327\u20132329 (2017).","journal-title":"Lancet"},{"key":"32012_CR5","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/S0140-6736(15)01124-1","volume":"388","author":"P Scheltens","year":"2016","unstructured":"Scheltens, P. et al. Alzheimer\u2019s disease. Lancet 388, 505\u2013517 (2016).","journal-title":"Lancet"},{"key":"32012_CR6","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/s41582-024-00940-4","volume":"20","author":"AD Korczyn","year":"2024","unstructured":"Korczyn, A. D. & Grinberg, L. T. Is alzheimer disease a disease? Nat. Reviews Neurol. 20, 245\u2013251 (2024).","journal-title":"Nat. Reviews Neurol."},{"key":"32012_CR7","doi-asserted-by":"publisher","first-page":"3208","DOI":"10.1007\/s11064-024-04244-3","volume":"49","author":"P Sharma","year":"2024","unstructured":"Sharma, P., Giri, A. & Tripathi, P. N. Emerging trends: Neurofilament biomarkers in precision neurology. Neurochem. Res. 49, 3208\u20133225 (2024).","journal-title":"Neurochem. Res."},{"key":"32012_CR8","doi-asserted-by":"publisher","first-page":"595","DOI":"10.15252\/emmm.201606210","volume":"8","author":"DJ Selkoe","year":"2016","unstructured":"Selkoe, D. J. & Hardy, J. The amyloid hypothesis of alzheimer\u2019s disease at 25 years. EMBO Mol. Med. 8, 595\u2013608 (2016).","journal-title":"EMBO Mol. Med."},{"key":"32012_CR9","doi-asserted-by":"publisher","first-page":"S123","DOI":"10.3233\/JAD-2012-129031","volume":"33","author":"JZ Wang","year":"2012","unstructured":"Wang, J. Z., Xia, Y. Y., Grundke-Iqbal, I. & Iqbal, K. Abnormal hyperphosphorylation of tau: Sites, regulation, and molecular mechanism of neurofibrillary degeneration. J. Alzheimer\u2019s Disease. 33, S123\u2013S139 (2012).","journal-title":"J. Alzheimer\u2019s Disease"},{"key":"32012_CR10","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1016\/j.neurobiolaging.2003.08.002","volume":"24","author":"SW Scheff","year":"2003","unstructured":"Scheff, S. W. & Price, D. A. Synaptic pathology in Alzheimer\u2019s disease: Aa review of ultrastructural studies. Neurobiol. Aging. 24, 1029\u20131046 (2003).","journal-title":"Neurobiol. Aging"},{"key":"32012_CR11","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1093\/brain\/awy132","volume":"141","author":"H Hampel","year":"2018","unstructured":"Hampel, H. et al. The cholinergic system in the pathophysiology and treatment of alzheimer\u2019s disease. Brain 141, 1917\u20131933 (2018).","journal-title":"Brain"},{"key":"32012_CR12","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1017\/S1461145705005833","volume":"9","author":"RM Lane","year":"2006","unstructured":"Lane, R. M., Potkin, S. G. & Enz, A. Targeting acetylcholinesterase and butyrylcholinesterase in dementia. Int. J. Neuropsychopharmacol. 9, 101\u2013124 (2006).","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"32012_CR13","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1586\/14737175.5.1.101","volume":"5","author":"A Tasker","year":"2005","unstructured":"Tasker, A., Perry, E. K. & Ballard, C. G. Butyrylcholinesterase: Impact on symptoms and progression of cognitive impairment. Expert Rev. Neurother. 5, 101\u2013106 (2005).","journal-title":"Expert Rev. Neurother."},{"key":"32012_CR14","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.2174\/156802612805219950","volume":"12","author":"M Naoi","year":"2012","unstructured":"Naoi, M., Maruyama, W. & Inaba-Hasegawa, K. Type A and B monoamine oxidase in age-related neurodegenerative disorders: Their distinct roles in neuronal death and survival. Curr. Top. Med. Chem. 12, 2177\u20132188 (2012).","journal-title":"Curr. Top. Med. Chem."},{"key":"32012_CR15","doi-asserted-by":"publisher","first-page":"114464","DOI":"10.1016\/j.ejmech.2022.114464","volume":"238","author":"Z Sang","year":"2022","unstructured":"Sang, Z., Wang, K., Dong, J. & Tang, L. Alzheimer\u2019s disease: Updated multi-targets therapeutics are in clinical and in progress. Eur. J. Med. Chem. 238, 114464 (2022).","journal-title":"Eur. J. Med. Chem."},{"key":"32012_CR16","doi-asserted-by":"publisher","first-page":"137841","DOI":"10.1016\/j.molstruc.2024.137841","volume":"1306","author":"S Jalil","year":"2024","unstructured":"Jalil, S. et al. Pristine 2-chloroquinoline-based-thiosemicarbazones as multitarget agents against alzheimer\u2019s disease: In vitro and in Silico studies of monoamine oxidase (MAO) and cholinesterase (ChE) inhibitors. J. Mol. Struct. 1306, 137841 (2024).","journal-title":"J. Mol. Struct."},{"key":"32012_CR17","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1007\/s11064-023-04081-w","volume":"49","author":"N Siddiqui","year":"2024","unstructured":"Siddiqui, N. et al. Multifaceted neuroprotective role of punicalagin: A review. Neurochem. Res. 49, 1427\u20131436 (2024).","journal-title":"Neurochem. Res."},{"key":"32012_CR18","doi-asserted-by":"publisher","first-page":"724","DOI":"10.62641\/aep.v52i5.1680","volume":"52","author":"S Jia","year":"2024","unstructured":"Jia, S., Guan, H., Zhang, S. & Li, Q. Schisandrin A alleviates inflammation and oxidative stress in A\u03b225-35-Induced alzheimer\u2019s disease in vitro model. Actas Esp. Psiquiatr. 52, 724 (2024).","journal-title":"Actas Esp. Psiquiatr."},{"key":"32012_CR19","doi-asserted-by":"publisher","first-page":"395","DOI":"10.3389\/fphar.2019.00395","volume":"10","author":"H Luo","year":"2019","unstructured":"Luo, H. et al. Apelin-13 suppresses neuroinflammation against cognitive deficit in a streptozotocin-induced rat model of alzheimer\u2019s disease through activation of BDNF-TrkB signaling pathway. Front. Pharmacol. 10, 395 (2019).","journal-title":"Front. Pharmacol."},{"key":"32012_CR20","doi-asserted-by":"publisher","first-page":"22645","DOI":"10.1038\/s41598-024-72858-2","volume":"14","author":"H Aftab","year":"2024","unstructured":"Aftab, H. et al. Design, synthesis, in vitro and in Silico studies of novel piperidine derived thiosemicarbazones as inhibitors of dihydrofolate reductase. Sci. Rep. 14, 22645 (2024).","journal-title":"Sci. Rep."},{"key":"32012_CR21","doi-asserted-by":"publisher","first-page":"31409","DOI":"10.1039\/D4RA05071A","volume":"14","author":"H Aftab","year":"2024","unstructured":"Aftab, H. et al. Synthesis, in vitro biological evaluation and in Silico studies of novel pyrrolidine derived thiosemicarbazones as dihydrofolate reductase inhibitors. RSC Adv. 14, 31409\u201331421 (2024).","journal-title":"RSC Adv."},{"key":"32012_CR22","doi-asserted-by":"publisher","first-page":"111620","DOI":"10.1016\/j.jinorgbio.2021.111620","volume":"225","author":"K Bajaj","year":"2021","unstructured":"Bajaj, K., Buchanan, R. M. & Grapperhaus, C. A. Antifungal activity of thiosemicarbazones, Bis (thiosemicarbazones), and their metal complexes. J. Inorg. Biochem. 225, 111620 (2021).","journal-title":"J. Inorg. Biochem."},{"key":"32012_CR23","doi-asserted-by":"crossref","unstructured":"Alam, M. et al. Synthesis, characterization, antibacterial activity of thiosemicarbazones derivatives and their computational approaches: Quantum calculation, molecular docking, molecular dynamic, ADMET, QSAR. Heliyon 9 (2023).","DOI":"10.1016\/j.heliyon.2023.e16222"},{"key":"32012_CR24","doi-asserted-by":"publisher","first-page":"108118","DOI":"10.1016\/j.bioorg.2024.108118","volume":"155","author":"J Eshal","year":"2025","unstructured":"Eshal, J. et al. Synthesis, biological evaluation, and in Silico studies of phenyl naphthalene-2-sulfonate derived thiosemicarbazones as potential carbonic anhydrase inhibitors. Bioorg. Chem. 155, 108118 (2025).","journal-title":"Bioorg. Chem."},{"key":"32012_CR25","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.ejmech.2017.08.021","volume":"139","author":"D Palanimuthu","year":"2017","unstructured":"Palanimuthu, D. et al. A novel class of thiosemicarbazones show multi-functional activity for the treatment of alzheimer\u2019s disease. Eur. J. Med. Chem. 139, 612\u2013632 (2017).","journal-title":"Eur. J. Med. Chem."},{"key":"32012_CR26","doi-asserted-by":"publisher","first-page":"176028","DOI":"10.1016\/j.ejphar.2023.176028","volume":"957","author":"M Varma","year":"2023","unstructured":"Varma, M. et al. Novel alkyl-substituted 4-methoxy benzaldehyde thiosemicarbazones: Multi-target directed ligands for the treatment of alzheimer\u2019s disease. Eur. J. Pharmacol. 957, 176028 (2023).","journal-title":"Eur. J. Pharmacol."},{"key":"32012_CR27","doi-asserted-by":"publisher","first-page":"17","DOI":"10.2147\/ciia.2007.2.1.17","volume":"2","author":"ML Onor","year":"2007","unstructured":"Onor, M. L., Trevisiol, M. & Aguglia, E. Rivastigmine in the treatment of alzheimer\u2019s disease: An update. Clin. Interv. Aging. 2, 17\u201332 (2007).","journal-title":"Clin. Interv. Aging"},{"key":"32012_CR28","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1111\/cns.13035","volume":"24","author":"A Adlimoghaddam","year":"2018","unstructured":"Adlimoghaddam, A., Neuendorff, M., Roy, B. & Albensi, B. C. A review of clinical treatment considerations of donepezil in severe alzheimer\u2019s disease. CNS Neurosci. Ther. 24, 876\u2013888 (2018).","journal-title":"CNS Neurosci. Ther."},{"key":"32012_CR29","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.3390\/pharmaceutics14061117","volume":"14","author":"T Pardo-Moreno","year":"2022","unstructured":"Pardo-Moreno, T. et al. Therapeutic approach to alzheimer\u2019s disease: Current treatments and new perspectives. Pharmaceutics 14, 1117 (2022).","journal-title":"Pharmaceutics"},{"key":"32012_CR30","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1002\/ddr.21515","volume":"80","author":"XH Gao","year":"2019","unstructured":"Gao, X. H., Tang, J. J., Liu, H. R., Liu, L. B. & Liu, Y. Z. Structure\u2013activity study of fluorine or chlorine-substituted cinnamic acid derivatives with tertiary amine side chain in acetylcholinesterase and butyrylcholinesterase Inhibition. Drug Dev. Res. 80, 438\u2013445 (2019).","journal-title":"Drug Dev. Res."},{"key":"32012_CR31","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1002\/ddr.21726","volume":"81","author":"QQ Lu","year":"2020","unstructured":"Lu, Q. Q. et al. Nitrogen-containing flavonoid and their analogs with diverse B\u2010ring in acetylcholinesterase and butyrylcholinesterase Inhibition. Drug Dev. Res. 81, 1037\u20131047 (2020).","journal-title":"Drug Dev. Res."},{"key":"32012_CR32","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1007\/s11030-018-9839-y","volume":"22","author":"L Kang","year":"2018","unstructured":"Kang, L. et al. Structure\u2013activity relationship investigation of coumarin\u2013chalcone hybrids with diverse side-chains as acetylcholinesterase and butyrylcholinesterase inhibitors. Mol. Diversity. 22, 893\u2013906 (2018).","journal-title":"Mol. Diversity"},{"key":"32012_CR33","first-page":"100172","volume":"11","author":"N Siddiqui","year":"2024","unstructured":"Siddiqui, N., Talib, M., Tripathi, P. N., Kumar, A. & Sharma, A. Therapeutic potential of Baicalein against neurodegenerative diseases: An updated review. Health Sci. Rev. 11, 100172 (2024).","journal-title":"Health Sci. Rev."},{"key":"32012_CR34","doi-asserted-by":"publisher","first-page":"2300430","DOI":"10.1002\/ardp.202300430","volume":"356","author":"R Basri","year":"2023","unstructured":"Basri, R. et al. 2-Oxoquinoline\u2010based\u2010thiosemicarbazones as multitargeting neurotherapeutics against alzheimer\u2019s disease: In vitro and in Silico studies of MAO and ChE inhibitors. Arch. Pharm. 356, 2300430 (2023).","journal-title":"Arch. Pharm."},{"key":"32012_CR35","doi-asserted-by":"publisher","first-page":"e2990","DOI":"10.1002\/jmr.2990","volume":"35","author":"AN Uytun","year":"2022","unstructured":"Uytun, A. N. et al. Synthesis of novel thiosemicarbazone derivatives and investigation of their dual ache and MAO-B inhibitor effects. J. Mol. Recognit. 35, e2990 (2022).","journal-title":"J. Mol. Recognit."},{"key":"32012_CR36","doi-asserted-by":"publisher","first-page":"5116","DOI":"10.1021\/acsomega.2c08108","volume":"8","author":"M Khan","year":"2023","unstructured":"Khan, M. et al. Para-substituted thiosemicarbazones as cholinesterase inhibitors: synthesis, in vitro biological evaluation, and in Silico study. ACS Omega. 8, 5116\u20135123 (2023).","journal-title":"ACS Omega"},{"key":"32012_CR37","doi-asserted-by":"publisher","first-page":"118301","DOI":"10.1016\/j.bmc.2025.118301","volume":"129","author":"I. Munir","year":"2025","unstructured":"Munir, I. et al. Synthesis of 6-ethoxyphenyl 4-fluorobenzenesulfonate-tagged thiosemicarbazones as carbonic anhydrase inhibitors: In-vitro and in Silico approach. Bioorgan Med. Chem. 129, 118301 (2025).","journal-title":"Bioorgan Med. Chem."},{"key":"32012_CR38","doi-asserted-by":"publisher","first-page":"e70050","DOI":"10.1002\/ardp.70050","volume":"358","author":"U Farooq","year":"2025","unstructured":"Farooq, U. et al. Design, synthesis, in vitro, and in silico studies of 5-(diethylamino)\u20102\u2010formylphenyl naphthalene\u20102\u2010sulfonate based thiosemicarbazones as potent anti\u2010Alzheimer agents. Arch. Pharm. 358, e70050 (2025).","journal-title":"Arch. Pharm."},{"key":"32012_CR39","doi-asserted-by":"publisher","first-page":"e70034","DOI":"10.1002\/ardp.70034","volume":"358","author":"U Ghaffar","year":"2025","unstructured":"Ghaffar, U. et al. Synthesis, anti-Alzheimer evaluation and in silico study of 4\u2010mMethoxyphenyl) sulfonyl indole hybrid thiosemicarbazones. Arch. Pharm. 358, e70034 (2025).","journal-title":"Arch. Pharm."},{"key":"32012_CR40","doi-asserted-by":"publisher","first-page":"5739","DOI":"10.1073\/pnas.0710626105","volume":"105","author":"S. Y. Son","year":"2008","unstructured":"Son, S. Y. et al. Structure of human monoamine oxidase A at 2.2-\u00c5 resolution: The control of opening the entry for substrates\/inhibitors. Proc. Natl. Acad. Sci. 105, 5739\u20135744 (2008).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"32012_CR41","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1021\/ml400304w","volume":"4","author":"J Cheung","year":"2013","unstructured":"Cheung, J., Gary, E. N., Shiomi, K. & Rosenberry, T. L. Structures of human acetylcholinesterase bound to Dihydrotanshinone I and territrem B show peripheral site flexibility. ACS Med. Chem. Lett. 4, 1091\u20131096 (2013).","journal-title":"ACS Med. Chem. Lett."},{"key":"32012_CR42","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1042\/BJ20130013","volume":"453","author":"F Nachon","year":"2013","unstructured":"Nachon, F. et al. Crystal structures of human cholinesterases in complex with Huprine W and tacrine: Elements of specificity for anti-Alzheimer\u2019s drugs targeting acetyl-and butyryl-cholinesterase. Biochem. J. 453, 393\u2013399 (2013).","journal-title":"Biochem. J."},{"key":"32012_CR43","unstructured":"BioSolveIT\u2019s LeadIT. 2.3.2, (2017). www.biosolveit.de\/LeadIT"},{"key":"32012_CR44","unstructured":"Desmond, M. D. System, version 2023.4, D. E (Shaw Research, )."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-32012-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-32012-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-32012-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T18:03:04Z","timestamp":1766167384000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-32012-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,13]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["32012"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-32012-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,13]]},"assertion":[{"value":"27 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"44212"}}